Description
A dual inhibitor of both PI3K and mTOR, completely blocking phosphorylation of substrates at 8-16 µM; induces cell death in GBM xenografts in vitro, with half maximal inhibition occurring at 3.7-7.7 µM; orally bioavailable, reducing the growth of intracranial GBM xenografts in mice
Formal name: N-[4-[[[3-[(3,5-dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methyl-benzamide
Synonyms: SAR245409|Voxtalisib
Molecular weight: 599.7
CAS: 1349796-36-6
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|mTOR||Product Type|Biochemicals|Kinase Inhibitors|PI3K||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|PI3K/Akt/mTOR Signaling